{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:08:27Z","timestamp":1782274107840,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS095239"],"award-info":[{"award-number":["NS095239"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2026.117685","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:01:34Z","timestamp":1767715294000},"page":"117685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Agonism of FFA4\/GPR120 activates tyrosine hydroxylase and confers neuroprotection from 6-OHDA-induced cytotoxicity in PC12 cells and in a rat 6-OHDA model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"245","author":[{"given":"Farnoosh","family":"Moghaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Binwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyn M.","family":"Rambacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Jarrett","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-4339","authenticated-orcid":false,"given":"Nader H.","family":"Moniri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2026.117685_b0005","doi-asserted-by":"crossref","first-page":"G716","DOI":"10.1152\/ajpgi.00383.2024","article-title":"Gut neuropeptide involvement in Parkinson\u2019s disease","volume":"328","author":"Templeton","year":"2025","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117685_b0010","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10787-025-01726-w","article-title":"Gut microbiota and Parkinson\u2019s disease: a new frontier in understanding neurological health","volume":"33","author":"Kumari","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"9996","key":"10.1016\/j.bcp.2026.117685_b0015","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/acschemneuro.8b00180","article-title":"Novel targets for Parkinson\u2019s disease: addressing different therapeutic paradigms and conundrums","volume":"10","author":"Rane","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.bcp.2026.117685_b0025","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00702-014-1238-7","article-title":"Complex molecular regulation of tyrosine hydroxylase","volume":"121","author":"Tekin","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bcp.2026.117685_b0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbrc.2021.12.024","article-title":"Tyrosine hydroxylase activity is regulated through the modification of the 176th cysteine residue","volume":"589","author":"Inukai","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"36","key":"10.1016\/j.bcp.2026.117685_b0035","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1016\/S0021-9258(18)35673-4","article-title":"Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis","volume":"267","author":"Wu","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2026.117685_b0040","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1021\/bi980582l","article-title":"Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: evidence for a novel regulatory mechanism","volume":"37","author":"Ramsey","year":"1998","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bcp.2026.117685_b0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-009-0227-8","article-title":"Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines","volume":"116","author":"Nakashima","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41467-021-27657-y","article-title":"Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation","volume":"13","author":"Bueno-Carrasco","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2026.117685_b0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/jnc.15963","article-title":"Tyrosine hydroxylase phosphorylation is under the control of serine 40","volume":"167","author":"Stoop","year":"2023","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117685_b0060","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","article-title":"Impact of dopamine oxidation on dopaminergic neurodegeneration","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2026.117685_b0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/1871527318666191114093749","article-title":"Omega-3 fatty acids as druggable therapeutics for neurodegenerative disorders","volume":"18","author":"Chitre","year":"2019","journal-title":"CNS Neurol. Disord.-Dr"},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/1028415X.2020.1735143","article-title":"Potential treatment of Parkinson\u2019s disease with omega-3 polyunsaturated fatty acids","volume":"25","author":"Li","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bcp.2026.117685_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107976","article-title":"Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson\u2019s disease via mechanisms associated with increased protein kinase activity in the striatum","author":"Chitre","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117685_b0080","article-title":"Free-fatty acid receptor-4 (GPR120): cellular and molecular function and its role in metabolic disorders","volume":"110\u2013111","author":"Moniri","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117685_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114483","article-title":"Short-chain free-fatty acid G protein-coupled receptors in colon cancer","volume":"186","author":"Moniri","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117685_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/bph.16225","article-title":"Gut feelings in the islets: the role of the gut microbiome and the SCFA receptors FFA2\/FFA3 on \u03b2-cell function and metabolic regulation","author":"Teyani","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117685_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108784","article-title":"Biased agonism at free-fatty acid receptor-4 (FFA4\/GPR120)","volume":"266","author":"Teyani","year":"2025","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12974-017-0869-7","article-title":"Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation","volume":"14","author":"Dragano","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"28","key":"10.1016\/j.bcp.2026.117685_b0110","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1523\/JNEUROSCI.2595-20.2021","article-title":"GPR120 signaling controls amyloid-\u03b2 degrading activity of matrix metalloproteinases","volume":"41","author":"Kikuchi","year":"2021","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117685_b0115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4049\/jimmunol.1800637","article-title":"Activation of the omega-3 fatty acid receptor GPR120 protects against focal cerebral ischemic injury by preventing inflammation and apoptosis in mice","volume":"202","author":"Ren","year":"2019","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12974-023-02978-5","article-title":"Central activation of the fatty acid sensor GPR120 suppresses microglia reactivity and alleviates sickness- and anxiety-like behaviors","volume":"20","author":"Nakajima","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.bcp.2026.117685_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114509","article-title":"An atlas of GPCRs in dopamine neurons: Identification of the free fatty acid receptor 4 as a regulator of food and water intake","volume":"43","author":"Apuschkin","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.117685_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2017.09.008","article-title":"Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal \u03b2-arrestin phosphosensor in Raw 264.7 macrophages","author":"Cheshmehkani","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117685_b0135","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708047","article-title":"The GPR120 agonist TUG-891 promotes metabolic health by stimulating mitochondrial respiration in brown fat","volume":"10","author":"Schilperoort","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.117685_b0140","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.113.087783","article-title":"The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism","volume":"84","author":"Hudson","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117685_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00735","article-title":"The GPR120 agonist TUG-891 mitigates ischemic brain injury by attenuating endoplasmic reticulum stress and apoptosis via the PI3K\/AKT signaling pathway","volume":"22","author":"Sun","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.bcp.2026.117685_b0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mol.119.117697","article-title":"Carboxy-terminal phosphoregulation of the long splice isoform of free-fatty acid receptor-4 mediates \u03b2-arrestin recruitment and signaling to ERK1\/2","volume":"97","author":"Senatorov","year":"2020","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117685_b0155","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bcp.2013.12.016","article-title":"Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr347, Ser350, and Ser357 in the C-terminal tail","volume":"87","author":"Burns","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117685_b0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2011.11.012","article-title":"Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system","volume":"1432","author":"Nakamoto","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2026.117685_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107432","article-title":"GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson\u2019s disease animal models","volume":"209","author":"Ha","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.117685_b0170","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1093\/jn\/133.11.3643","article-title":"Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study","volume":"133","author":"Kuriki","year":"2003","journal-title":"J. Nutr."},{"issue":"14","key":"10.1016\/j.bcp.2026.117685_b0175","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.bmcl.2014.05.012","article-title":"Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4\/GPR120)","volume":"24","author":"Sparks","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bcp.2026.117685_b0180","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117685_b0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.bcp.2026.117685_b0190","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease: mechanisms, biomarkers, and therapeutic strategies","author":"Usha Kiran","year":"2025","journal-title":"Tissue Barriers"},{"issue":"9","key":"10.1016\/j.bcp.2026.117685_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom15091252","article-title":"Mitochondrial aging in the CNS: unravelling implications for neurological health and disease","volume":"15","author":"Steffan","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.117685_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103787","article-title":"Decoding Parkinson\u2019s disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations","volume":"85","author":"Liu","year":"2025","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117685_b0205","article-title":"Exploring the role of reactive oxygen species in the pathogenesis and pathophysiology of Alzheimer\u2019s and Parkinson\u2019s disease and the efficacy of antioxidant treatment","volume":"13","author":"Gogna","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bcp.2026.117685_b0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2020.00068","article-title":"Nuclear factor-\u03baB dysregulation and \u03b1-synuclein pathology: critical interplay in the pathogenesis of Parkinson\u2019s disease","volume":"12","author":"Bellucci","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117685_b0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","article-title":"NF-\u03baB-mediated neuroinflammation in Parkinson\u2019s disease and potential therapeutic effect of polyphenols","volume":"37","author":"Singh","year":"2020","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2005.07.183","article-title":"Regulatory mechanism of tyrosine hydroxylase activity","volume":"338","author":"Fujisawa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.117685_b0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-0-12-411512-5.00002-6","article-title":"Tyrosine hydroxylase: regulation by feedback inhibition and phosphorylation","volume":"68","author":"Dickson","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117685_b0230","article-title":"Intracrine FFA4 signaling controls lipolysis at lipid droplets","author":"O\u2019Brien","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"6640","key":"10.1016\/j.bcp.2026.117685_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6220","article-title":"Unsaturated bond recognition leads to biased signal in a fatty acid receptor","volume":"380","author":"Mao","year":"2023","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2026.117685_b0240","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj2384","article-title":"Structural basis for the ligand recognition and signaling of free fatty acid receptors","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.bcp.2026.117685_b0245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/mol.115.101949","article-title":"Distinct phosphorylation clusters determine the signaling outcome of free fatty acid receptor 4\/G protein-coupled receptor 120","volume":"89","author":"Prihandoko","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"53","key":"10.1016\/j.bcp.2026.117685_b0250","doi-asserted-by":"crossref","first-page":"27147","DOI":"10.1074\/jbc.M116.754887","article-title":"Targeted elimination of G proteins and arrestins defines their specific contributions to both intensity and duration of G protein-coupled receptor signaling","volume":"291","author":"Alvarez-Curto","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"Pt A","key":"10.1016\/j.bcp.2026.117685_b0255","article-title":"\u03b1-linolenic acid mitigates microglia-mediated neuroinflammation of schizophrenia in mice by suppressing the NF-\u03baB\/NLRP3 pathway via binding GPR120-\u03b2-arrestin 2","volume":"142","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0260","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12974-021-02361-2","article-title":"A peripheral lipid sensor GPR120 remotely contributes to suppression of PGD(2)-microglia-provoked neuroinflammation and neurodegeneration in the mouse hippocampus","volume":"18","author":"Iwasa","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.bcp.2026.117685_b0265","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40120-024-00687-6","article-title":"Sex differences in Parkinson\u2019s disease: a narrative review","volume":"14","author":"Cattaneo","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.bcp.2026.117685_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111821","article-title":"Sex and gender differences in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis: a narrative review","volume":"212","author":"Nicoletti","year":"2023","journal-title":"Mech. Ageing Dev."},{"issue":"2","key":"10.1016\/j.bcp.2026.117685_b0280","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2026.117685_b0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neubiorev.2015.09.024","article-title":"Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson\u2019s disease","volume":"67","author":"Litim","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.117685_b0290","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11481-020-09972-1","article-title":"Brain selective estrogen treatment protects dopaminergic neurons and preserves behavioral function in MPTP-induced mouse model of Parkinson\u2019s disease","volume":"16","author":"Thadathil","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2026.117685_b0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yhbeh.2016.01.011","article-title":"Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice","volume":"80","author":"Hwang","year":"2016","journal-title":"Horm. Behav."},{"issue":"3","key":"10.1016\/j.bcp.2026.117685_b0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1262\/jrd.2019-166","article-title":"mRNA expression in gonadotropes in the mouse pituitary gland is regulated by free fatty acids","volume":"66","author":"Deura","year":"2020","journal-title":"J. Reprod. Dev."},{"issue":"10","key":"10.1016\/j.bcp.2026.117685_b0305","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1210\/en.2011-1167","article-title":"Unsaturated fatty acids stimulate LH secretion via novel PKCepsilon and -theta in gonadotrope cells and inhibit GnRH-induced LH release","volume":"152","author":"Garrel","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117685_b0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00418-014-1257-3","article-title":"Expression of the long-chain fatty acid receptor GPR120 in the gonadotropes of the mouse anterior pituitary gland","volume":"143","author":"Moriyama","year":"2015","journal-title":"Histochem. Cell Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:13:59Z","timestamp":1781698439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"alternative-id":["S000629522600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117685","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agonism of FFA4\/GPR120 activates tyrosine hydroxylase and confers neuroprotection from 6-OHDA-induced cytotoxicity in PC12 cells and in a rat 6-OHDA model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117685"}}